bretylium tosylate has been researched along with bethanidine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (87.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Krieglstein, GK | 1 |
| Kabell, G | 1 |
| Somberg, J | 1 |
| Somberg, JC | 1 |
| Bacaner, M | 1 |
| Bacaner, MB; Benditt, DG | 1 |
| Bacaner, MB; Hoey, MF; Macres, MG | 1 |
2 review(s) available for bretylium tosylate and bethanidine
| Article | Year |
|---|---|
Antiarrhythmic drug therapy. Recent advances and current status.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Bepridil; Bethanidine; Bretylium Tosylate; Disopyramide; Drug Administration Schedule; Encainide; Flecainide; Heart Conduction System; Humans; Imidazoles; Lidocaine; Mexiletine; Moricizine; Myocardial Contraction; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Pyrrolidines; Quinidine; Tocainide; Verapamil | 1985 |
Prophylaxis and therapy of ventricular fibrillation: bretylium reviewed and lidocaine refuted.
Topics: Animals; Anti-Arrhythmia Agents; Bethanidine; Bretylium Compounds; Bretylium Tosylate; Electrocardiography; Humans; Lidocaine; Myocardial Contraction; Stimulation, Chemical; Ventricular Fibrillation | 1983 |
6 other study(ies) available for bretylium tosylate and bethanidine
| Article | Year |
|---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
[The effect of sympatholytics on the intraocular pressure in the rabbit eye].
Topics: Animals; Bethanidine; Bretylium Tosylate; Guanethidine; Intraocular Pressure; Rabbits; Sympatholytics | 1977 |
Ischemia-induced conduction delay and ventricular arrhythmias: comparative electropharmacology of bethanidine sulfate and bretylium tosylate.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Bethanidine; Bretylium Compounds; Bretylium Tosylate; Coronary Disease; Dogs; Guanidines; Heart Conduction System; Perfusion; Rabbits; Tachycardia; Time Factors; Ventricular Fibrillation | 1989 |
New directions in antiarrhythmic drug therapy.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Benzeneacetamides; Bepridil; Bethanidine; Bretylium Tosylate; Death, Sudden; Disopyramide; Encainide; Flecainide; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Piperidines; Procainamide; Propafenone; Propiophenones; Pyrrolidines; Quinidine; Tachycardia; Tocainide; Verapamil | 1984 |
Antiarrhythmic, antifibrillatory, and hemodynamic actions of bethanidine sulfate: an orally effective analog of bretylium for suppression of ventricular tachyarrhythmias.
Topics: Adult; Aged; Arrhythmias, Cardiac; Bethanidine; Bretylium Tosylate; Depression, Chemical; Dose-Response Relationship, Drug; Electrophysiology; Female; Guanidines; Hemodynamics; Humans; Long-Term Care; Male; Middle Aged; Tachycardia; Ventricular Fibrillation | 1982 |
Suppression of ventricular fibrillation and positive inotropic action of bethanidine sulfate, a chemical analog of bretylium tosylate that is well absorbed orally.
Topics: Administration, Oral; Animals; Bethanidine; Blood Pressure; Bretylium Tosylate; Cardiac Output; Coronary Circulation; Dogs; Guanidines; Myocardial Contraction; Myocardial Infarction; Stimulation, Chemical; Structure-Activity Relationship; Ventricular Fibrillation | 1982 |